Gauri Kulkarni
Overview
Explore the profile of Gauri Kulkarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
525
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hinge S, Dhole S, Banpurkar A, Kulkarni G
Biochim Biophys Acta Gen Subj
. 2024 Dec;
1869(2):130744.
PMID: 39694299
Understanding the folding and unfolding mechanism of the protein is not only crucial in applications like biomedical, pharmaceutical, tissue engineering but also to the food industry. In the present study,...
2.
Hinge S, Dhole S, Banpurkar A, Kulkarni G
Dose Response
. 2024 Apr;
22(2):15593258241240233.
PMID: 38576528
In this work, we study the effect of 6 MeV electron beam irradiation on the physicochemical properties of lyophilized Human Haemoglobin A (HbA). Electron beams generated from Race Track Microtron...
3.
Ewart L, Apostolou A, Briggs S, Carman C, Chaff J, Heng A, et al.
Commun Med (Lond)
. 2023 Feb;
3(1):16.
PMID: 36732600
No abstract available.
4.
Ewart L, Apostolou A, Briggs S, Carman C, Chaff J, Heng A, et al.
Commun Med (Lond)
. 2023 Jan;
3(1):7.
PMID: 36635369
No abstract available.
5.
Ewart L, Apostolou A, Briggs S, Carman C, Chaff J, Heng A, et al.
Commun Med (Lond)
. 2022 Dec;
2(1):154.
PMID: 36473994
Background: Conventional preclinical models often miss drug toxicities, meaning the harm these drugs pose to humans is only realized in clinical trials or when they make it to market. This...
6.
Kulkarni G, Apostolou A, Ewart L, Lucchesi C, Kasendra M
J Vis Exp
. 2022 May;
(183).
PMID: 35604153
The intestinal mucosa is a complex physical and biochemical barrier that fulfills a myriad of important functions. It enables the transport, absorption, and metabolism of nutrients and xenobiotics while facilitating...
7.
Nawroth J, Petropolis D, Manatakis D, Maulana T, Burchett G, Schlunder K, et al.
Cell Rep
. 2021 Jul;
36(3):109393.
PMID: 34289365
Alcohol-associated liver disease (ALD) is a global health issue and leads to progressive liver injury, comorbidities, and increased mortality. Human-relevant preclinical models of ALD are urgently needed. Here, we leverage...
8.
Apostolou A, Panchakshari R, Banerjee A, Manatakis D, Paraskevopoulou M, Luc R, et al.
Cell Mol Gastroenterol Hepatol
. 2021 Jul;
12(5):1719-1741.
PMID: 34284165
Background & Aims: The limited availability of organoid systems that mimic the molecular signatures and architecture of human intestinal epithelium has been an impediment to allowing them to be harnessed...
9.
Khater M, Khater S, Gholap H, Patil R, Kulkarni G
J Microbiol Methods
. 2020 Apr;
173:105920.
PMID: 32304720
Many methods are developed to assess antimicrobial action of ZnO nanoparticles (NPs). A large number of methods associated with the use of fluorescent probes are developed, including Spectrofluorometry, fluorescence microscopy,...
10.
Kasendra M, Luc R, Yin J, Manatakis D, Kulkarni G, Lucchesi C, et al.
Elife
. 2020 Jan;
9.
PMID: 31933478
Induction of intestinal drug metabolizing enzymes can complicate the development of new drugs, owing to the potential to cause drug-drug interactions (DDIs) leading to changes in pharmacokinetics, safety and efficacy....